The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part 2 of the interview discussing the FAME 3 substudy.
The abstract entitled ‘FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs Functional Significance and Prognostic Value of Post-PCI FFR II’ was presented at the Transcatheter Cardiovascular Therapeutics (TCT) conference, 16 – 19, September 2022.
Question:
What was known about the value of measuring post-PCI FFR and intravascular imaging in patients with coronary artery disease? (0:22)
Disclosures: Zsolt Piroth is on the advisory board for Abbott and the speaker’s bureau and a consultant for Abbott, Boston Scientific and OpSens.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of TCT 2022
Access more content on Interventional Cardiology here and Cardiovascular Disease here
